Literature DB >> 2152996

Protection from lethal coronavirus infection by affinity-purified spike glycoprotein of murine hepatitis virus, strain A59.

C Daniel1, P J Talbot.   

Abstract

Murine hepatitis viruses provide excellent animal models for the study of virus-induced diseases of the central nervous system and gastrointestinal tract. Several studies have indirectly provided evidence that the spike glycoprotein (S) of these coronaviruses bears determinants for pathogenesis and the induction of protective immunity. In order to directly evaluate the immunogenicity of this protein, it was purified by affinity chromatography with an in vitro neutralizing and in vivo protective monoclonal antibody which immunoprecipitated the 180-kDa spike glycoprotein of the neurotropic A59 strain of murine hepatitis virus (MHV-A59). Mice immunized twice with approximately 1 micrograms of purified S in Freund's adjuvant developed high titers of neutralizing and fusion inhibiting antibodies, even though the protein was at least partially denaturated after elution from the affinity column. Moreover, these mice were protected from lethal encephalitis when challenged intracerebrally with 10 LD50 of MHV-A59. This study provides a direct demonstration of the importance of the coronavirus spike glycoprotein in the induction of a protective immune response.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2152996      PMCID: PMC7131235          DOI: 10.1016/0042-6822(90)90057-x

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  31 in total

1.  The purification of four respiratory syncytial virus proteins and their evaluation as protective agents against experimental infection in BALB/c mice.

Authors:  E G Routledge; M M Willcocks; A C Samson; L Morgan; R Scott; J J Anderson; G L Toms
Journal:  J Gen Virol       Date:  1988-02       Impact factor: 3.891

2.  The peplomer protein E2 of coronavirus JHM as a determinant of neurovirulence: definition of critical epitopes by variant analysis.

Authors:  H Wege; J Winter; R Meyermann
Journal:  J Gen Virol       Date:  1988-01       Impact factor: 3.891

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Hybridoma antibodies to the murine coronavirus JHM: characterization of epitopes on the peplomer protein (E2).

Authors:  H Wege; R Dörries; H Wege
Journal:  J Gen Virol       Date:  1984-11       Impact factor: 3.891

5.  The use of avidin-biotin interaction in immunoenzymatic techniques.

Authors:  J L Guesdon; T Ternynck; S Avrameas
Journal:  J Histochem Cytochem       Date:  1979-08       Impact factor: 2.479

Review 6.  NEUTRAL SALTS: THE GENERALITY OF THEIR EFFECTS ON THE STABILITY OF MACROMOLECULAR CONFORMATIONS.

Authors:  P H VONHIPPEL; K Y WONG
Journal:  Science       Date:  1964-08-07       Impact factor: 47.728

7.  Vaccination against lethal coronavirus-induced encephalitis with a synthetic decapeptide homologous to a domain in the predicted peplomer stalk.

Authors:  P J Talbot; G Dionne; M Lacroix
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

8.  Proteolytic cleavage of the E2 glycoprotein of murine coronavirus: activation of cell-fusing activity of virions by trypsin and separation of two different 90K cleavage fragments.

Authors:  L S Sturman; C S Ricard; K V Holmes
Journal:  J Virol       Date:  1985-12       Impact factor: 5.103

9.  Physico-chemical properties of murine hepatitis virus, strain A 59. Brief report.

Authors:  C Daniel; P J Talbot
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

10.  Monoclonal antibodies to the matrix (E1) glycoprotein of mouse hepatitis virus protect mice from encephalitis.

Authors:  J O Fleming; R A Shubin; M A Sussman; N Casteel; S A Stohlman
Journal:  Virology       Date:  1989-01       Impact factor: 3.616

View more
  27 in total

1.  Identification of an immunodominant linear neutralization domain on the S2 portion of the murine coronavirus spike glycoprotein and evidence that it forms part of complex tridimensional structure.

Authors:  C Daniel; R Anderson; M J Buchmeier; J O Fleming; W J Spaan; H Wege; P J Talbot
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

2.  Protective immunity against murine hepatitis virus (MHV) induced by intranasal or subcutaneous administration of hybrids of tobacco mosaic virus that carries an MHV epitope.

Authors:  M Koo; M Bendahmane; G A Lettieri; A D Paoletti; T E Lane; J H Fitchen; M J Buchmeier; R N Beachy
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

3.  Comparison of bovine coronavirus (BCV) antigens: monoclonal antibodies to the spike glycoprotein distinguish between vaccine and wild-type strains.

Authors:  K A Hussain; J Storz; K G Kousoulas
Journal:  Virology       Date:  1991-07       Impact factor: 3.616

4.  Persistent infection of human oligodendrocytic and neuroglial cell lines by human coronavirus 229E.

Authors:  N Arbour; S Ekandé; G Côté; C Lachance; F Chagnon; M Tardieu; N R Cashman; P J Talbot
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

5.  Anti-severe acute respiratory syndrome coronavirus spike antibodies trigger infection of human immune cells via a pH- and cysteine protease-independent FcγR pathway.

Authors:  Martial Jaume; Ming S Yip; Chung Y Cheung; Hiu L Leung; Ping H Li; Francois Kien; Isabelle Dutry; Benoît Callendret; Nicolas Escriou; Ralf Altmeyer; Beatrice Nal; Marc Daëron; Roberto Bruzzone; J S Malik Peiris
Journal:  J Virol       Date:  2011-07-20       Impact factor: 5.103

6.  Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor.

Authors:  Gregory J Babcock; Diana J Esshaki; William D Thomas; Donna M Ambrosino
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

7.  Coronavirus infection in the laboratory rat: immunization trials using attenuated virus replicated in L-2 cells.

Authors:  D H Percy; R A Scott
Journal:  Can J Vet Res       Date:  1991-01       Impact factor: 1.310

8.  The S1 glycoprotein but not the N or M proteins of avian infectious bronchitis virus induces protection in vaccinated chickens.

Authors:  J Ignjatovic; L Galli
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

9.  Coronavirus infections in the laboratory rat: degree of cross protection following immunization with a heterologous strain.

Authors:  C G Bihun; D H Percy
Journal:  Can J Vet Res       Date:  1994-07       Impact factor: 1.310

10.  Major receptor-binding and neutralization determinants are located within the same domain of the transmissible gastroenteritis virus (coronavirus) spike protein.

Authors:  M Godet; J Grosclaude; B Delmas; H Laude
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.